Literature DB >> 14602267

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases.

Stuart W Jamieson1, David P Kapelanski, Naohide Sakakibara, Gerard R Manecke, Patricia A Thistlethwaite, Kim M Kerr, Richard N Channick, Peter F Fedullo, William R Auger.   

Abstract

BACKGROUND: The incidence of pulmonary hypertension resulting from chronic thrombotic occlusion of the pulmonary arteries is significantly underestimated. Although medical therapy for the condition is supportive only, surgical therapy is curative. Our pulmonary endarterectomy program was begun in 1970, and 188 patients were operated on in the subsequent 20 years. With the increased recognition of the disease and the success of operative therapy, however, more than 1,400 operations have been done since 1990 at our center.
METHODS: The safety and efficacy of the operation was assessed with changes made through increased experience. We examined in detail the results of our last 500 consecutive patients.
RESULTS: Median sternotomy, cardiopulmonary bypass, profound hypothermia, and circulatory arrest were found to be essential to the success of the operation. All occluding material could be removed at operation. We currently believe that there is no degree of embolic occlusion within the pulmonary vascular tree that is inaccessible and no degree of right ventricular impairment or any level of pulmonary vascular resistance that is inoperable. With shorter cardiac arrest periods and the use of a cooling jacket to the head, cerebral impairment has been eliminated. The pulmonary artery pressures and pulmonary vascular resistance in a recent cohort of 500 patients is examined. The mortality rate for the operation has been reduced steadily, and was 22 of the last 500 patients operated on (4.4%).
CONCLUSIONS: The operation is considered curative and therefore greatly superior to transplantation for this condition. Current techniques of operation make the procedure relatively safe.

Entities:  

Mesh:

Year:  2003        PMID: 14602267     DOI: 10.1016/s0003-4975(03)00828-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  133 in total

Review 1.  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors:  George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy.

Authors:  Kim M Kerr; William R Auger; James J Marsh; Gehan Devendra; Roger G Spragg; Nick H Kim; Richard N Channick; Stuart W Jamieson; Michael M Madani; Gerard R Manecke; David M Roth; Gordon P Shragg; Peter F Fedullo
Journal:  Chest       Date:  2011-08-11       Impact factor: 9.410

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Short-term intravenous iloprost for treatment of reperfusion lung oedema after pulmonary thromboendarterectomy.

Authors:  Hsao-Hsun Hsu; Jin-Shing Chen; Yih-Sharng Chen; Wen-Je Ko; Shuenn-Wen Kuo; Yung-Chie Lee
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

Review 5.  Chronic thromboembolic pulmonary hypertension (CTEPH).

Authors:  Keith McNeil; John Dunning
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

6.  Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.

Authors:  John J Ryan; Stuart Rich; Stephen L Archer
Journal:  Can J Cardiol       Date:  2011-10-22       Impact factor: 5.223

7.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

8.  Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography.

Authors:  Munehiro Sugiyama; Tetsuya Fukuda; Yoshihiro Sanda; Yoshiaki Morita; Masahiro Higashi; Takeshi Ogo; Akihiro Tsuji; Jun Demachi; Norifumi Nakanishi; Hiroaki Naito
Journal:  Jpn J Radiol       Date:  2014-04-24       Impact factor: 2.374

9.  Dual-energy CT for differentiating acute and chronic pulmonary thromboembolism: an initial experience.

Authors:  Seung-Seob Kim; Jin Hur; Young Jin Kim; Hye-Jeong Lee; Yoo Jin Hong; Byoung Wook Choi
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-06       Impact factor: 2.357

10.  Chronic thromboembolic pulmonary hypertension.

Authors:  Lara M Wittine; William R Auger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.